Sustained Anti-VEGF Delivery via Hydrogel Implant Achieves Non-Inferior Visual and Anatomical Outcomes in Neovascular AMD: A 24-Month Randomized Controlled Trial. sjo. 2026;8(2):486-493. doi:10.37275/sjo.v8i2.138